Importance and Relevance of Phytochemicals Present in <i>Galenia africana</i>

Heredia, Dario; Green, Ivan; Klaasen, Jeremy; Rahiman, Farzana

doi:https://doi.org/10.1155/2022/5793436

Scientifica

On this page

Abstract Introduction Materials and Methods Results and Discussion Conclusions Disclosure Conflicts of Interest Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2022 | Article ID 5793436 | https://doi.org/10.1155/2022/5793436

Importance and Relevance of Phytochemicals Present in Galenia africana

Dario Heredia,¹Ivan Green,²Jeremy Klaasen,¹and Farzana Rahiman^1,3

Academic Editor: Luis T. Ortiz

Received29 Jul 2021

Revised03 Dec 2021

Accepted17 Dec 2021

Published25 Jan 2022

Abstract

Many people in developing countries rely primarily on medicinal plants as their main source of healthcare, particularly for the treatment of skin infections. Despite the widespread use of medicinal plants, there is a lack of literature describing the relevance and risks of exposure of the phytochemicals present. Galenia africana has been used traditionally in the form of pastes, decoctions, and lotions to treat wounds and other skin-related ailments. This is a report on the phytochemical composition of G. africana and a review on the pharmacological importance and relevance of these phytochemicals. The major groups of phytochemicals identified in G. africana extracts were aliphatics, aliphatic triterpenoids, fatty acids, flavonoids, and phenolic and tocopherol compounds. These have been found to exhibit medicinal properties, thus highlighting the need to assess the safety of G. africana for topical application. The information related to the safety of the various compounds could indicate the potential risks related to accidental intake of the extract upon topical product applications. This report concludes that the quantities of the phytochemicals present in G. africana should not cause undue risk to human health, which provides comfort to pursue future work on using and developing G. africana as a therapeutic agent.

1. Introduction

Approximately 70–95% of the population in developing countries rely on medicinal plants as their primary source of healthcare [1]. These medicinal plants are highly sought after due to their apparent ability to treat burns and promote wound healing [1]. The use of such plants as a treatment option for skin infections has become common practice in many rural areas [2]. It has been reported that approximately 27 million people in South Africa rely on the use of medicinal plants to treat skin infections, in particular those caused by pathogens such as Staphylococci species and Candida albicans [3].

The Galenia africana plant species also known as ‘kraalbos’ or ‘geelbos’, belonging to the family Aizoaceae, is endemic to Southern Africa, where it is most commonly found in the Namaqualand region of South Africa, but has recently become more widespread in the Western and Southern Karoo [4–6]. Kraalbos is an aromatic, woody perennial sub-shrub which grows to a height of 0.5–1.5 m high, having oppositely arranged green leaves of about 5 cm long and hairless, which tend to change from green to yellow with age. The terminal ends of the twigs are the sites at which numerous small yellow flowers, about 1.5 mm in diameter, are born in large loose heads, during their blooming season; between October and December [5, 7, 8]. Kraalbos is considered a highly invasive pioneer plant, being the first perennial to regrow after soil disturbances, and the only remaining species after the veld has been heavily overgrazed. Some local farmers claim that during the summer months the plant is poisonous to goats and sheep [4]. According to other farmers, if kraalbos is green, it is palatable and not poisonous, but if it is yellow and dry, it is non-palatable and poisonous [9].

Traditional uses of G. africana by the southern African indigenous Khoi-San people involve chewing the plant to relieve toothache or preparing a decoction which is used to make a lotion for the treatment of wounds [10, 11]. It has been shown that frying G. africana with other medicinal plants in butter to create an ointment has been used to treat wounds, particularly on the legs of women [10]. Other uses which have been described in ethnobotanical surveys include making a leaf infusion to wash their heads for the purpose of treating pimples and rashes on the affected area. The same infusion was also used in the treatment of dandruff, lice, dry skull, leg pains, and swollen legs. In addition, topical products are prepared for the treatment of venereal diseases as well as skin infections and ailments such as ringworm [6, 12]. There have also been reports of G. africana leaves being used for chest pains, and conditions such as asthma and tuberculosis [11]. The medicinal potential of botanicals and natural ingredients derived from G. africana could be attributed to the plant being a major source of polyphenolic flavonoids and other compounds which are associated with antioxidant activities [13].

The aim of this study is to report on the phytochemical composition of G. africana and provide a comprehensive background on the pharmacological importance and relevance of these phytochemicals. The valuable information gained from such a study of the phytochemicals present in G. africana will highlight the importance and relevance for treatment of skin diseases described through traditional applications and ethnobotanical surveys. A review on dietary intake of the phytochemicals was used to inform potential health risks after accidental intake of the G. africana extract.

2. Materials and Methods

2.1. Identification of Phytochemicals of Galenia africana

It is important that medicinal plants be analysed to determine their phytochemical constituents, which would be beneficial in understanding the pharmacological importance and health risks. The first preparation of a G. africana extracts for antifungal and antibacterial fractionation including phytochemical identification studies was employed by Vries et al. (2005) and Mativandlela et al. (2009) [14, 15]. A study by Ticha et al. (2015) analysed a representative 20% extract (80% ethanol : water) of G. africana, obtained from Parceval Pharmaceuticals (Pty) Ltd (South Africa), using gravity liquid column chromatography (GLCC) to afford several fractions, which differ in levels of purity, and using EtOAc : hexane as a gradient eluent (hexane, hexane : EtOAc, and EtOAc) [13]. In this study, six of these fractions (A-F) were received as a gift from Dr. Lawrence Ticha, prepared during his postgraduate studies at the Chemistry Department, University of the Western Cape, and these fractions were subjected to a direct gas chromatography-mass spectrometry (GC-MS) analysis, as described by Al-Asmari et al. (2015) [16]. The GC-MS was performed at the Central Analytical Facilities, University of Stellenbosch, with results illustrated in Table 1. Nuclear magnetic resonance (¹H and ¹³C NMR) spectra were recorded in either CDCl₃ or acetone-d6 on a Varian Gemini 2000 spectrometer at 200.05 MHz for ¹H and 50.3 MHz for ¹³C spectra, respectively. All chemical shifts are expressed in parts per million (ppm) relative to trimethylsilane (TMS) as the internal reference standard. GC-MS analysis was carried out in a GC system (Agilent 7890A series, USA) equipped with split/splitless injector and autosampler attached to an apolar 5-MS (5% phenylpolymethyl siloxane) capillary column (Agilent 19091S-43; 30 m × 0.25 mm i.d. and 0.25- μm film thickness) and fitted to mass detector (Agilent 5975C series, USA). The flow rate of the carrier gas, helium (He) was set to be at 1 ml.min−1, split ratio is 1 : 50. The injector temperature was adjusted at 250°C, while the detector temperature was fixed to 280°C. The column temperature was kept at 40°C for 1 min followed by linear programming to raise the temperature from 40° to 120°C (at 4°C min−1 with 2 min hold time), 120°C to 170°C (at 6°C min−1 with 1 min hold time), and 170°C to 200°C (at 10°C min⁻¹ with 1 min hold time). The transfer line was heated at 280°C. Two microliters of sample was injected for analysis. Mass spectra were acquired in scan mode (70 eV), in the range of 50 to 550 m/z [16].

Positive identification of compounds was made by matching mass spectra against a reference library database, with results illustrated in the chromatogram (Figure 1) and compound structures in Table 1. Various flavonoids, isolated by gravity chromatographic separation and NMR analysis (Figure 2), and reported by Ticha et al. (2015) [13], are also included in Table 1. These clearly demonstrate that flavonoids were the major secondary plant metabolites present and possible activity was expected to result from these compounds as several previous studies have shown these compounds to have beneficial effects [13]. The relative concentration percentage (%) of any compound was calculated by the individual GC-MS peak area divided by the total peak area of the fraction and multiplying the result by 100.

(a)

(b)

2.2. Dietary Risk Analysis

APC Pharmaceuticals and Chemicals, United Kingdom, was contracted by the University of the Western Cape to conduct a toxicological review and health risk assessment of the components of the G. africana extract for agriculture operators and consumers. Since the extract is composed of about 61 compounds, most of which are already present in the human diet, an alternative to conventional toxicity testing procedures was proposed, thereby reducing laboratory animal use and minimising development costs and timeline. An alternative proposed by APC was to utilise peer reviewed literature to assess background dietary exposures for each component. The background dietary intake of the constituents of G. africana was analysed using the European Union Pesticide Residue Intake Model (EU PRIMO) consumer risk assessment model which informed a risk assessment for consumers. All compounds approved by the risk assessment were deemed to be nontoxic at the indicated concentration intakes and therefore did not pose a risk to human health, except cinnamic acid, the coumarins, equol, and 2-methoxy-4-vinyl phenol. The dietary intakes for the phytochemicals, as far as could be established from the literature, are summarised and referenced in Table 1 and the discussion.

2.3. Literature Search

An initial literature search was conducted with a combination of keywords such as Galenia africana, distribution, traditional use, medicinal uses, ethnomedicinal uses, phytochemistry, and chemical composition. After data for the phytochemical composition of Galenia africana was established, an extended literature search was performed to determine the natural occurrence and phytochemical and toxicological relevance of the individual constituents. This was done using a combination of the phytochemical name and keywords such as pharmacology, antioxidant, antiproliferative, antifungal, antibacterial, anti-inflammatory, wound healing, and toxicity. These searches were conducted using major databases, including Science Direct, Google Scholar, BioMed Central (BMC), Web of Science, Springer link, Scopus, and PubMed.

3. Results and Discussion

Results about the phytochemical composition of Galenia africana extract fractions and dietary intake risk in humans are shown in the chromatogram (Figure 1) and Table 1. Figure 2 details the calculated spectrum and 1H NMR spectrum of the flavonoid 2′,4′-dihydroxydihydrochalcone.

4. Natural Occurrence and Pharmacological Relevance of Phytochemicals Identified in the Galenia Africana Extract

The components contained in the G. africana extracts and their relative concentrations are listed in Table 1. Additionally, each of these phytochemical constituents was placed into one of the following groups: aliphatics, aliphatic triterpenoids, fatty acids, flavonoids, tocopherols, and phenolic compounds. The natural occurrence and pharmacological relevance for the compounds as far as could be established from the literature are outlined below.

4.1. Aliphatics

Aliphatics are a class of hydrocarbons, where medium and long chain alkanes are components of the surface waxy cuticle of plants and fruits. The function of this waxy layer is to control the rate of moisture loss and to provide a first line of defence against pathogenic organisms [34]. Humans are also exposed to paraffins and waxes from industrial origin, mainly via transfer of these compounds from packaging materials and through the pharmaceutical uses of paraffins. Heptacosane, nonacosane, and pentacosane have all been shown to possess antibacterial activity [35]. Hexacosane extracted from Sanseveria liberica was shown to exhibit moderately high antimicrobial activities against Salmonella typhi, Candida albicans, Streptococcus pyogenes, Staphylococcus aureus, Escherichia coli, Pseudomonas fluorescence, Klebsiella pneumoniae, Proteus vulgaris, and Candida krusei [36]. Due to limited information from the literature, specific pharmacological relevance of the remaining compounds classed under the aliphatic group could not be determined.

4.2. Aliphatic Triterpenoids

Farnesol, farnesyl acetone, hexahydrofarnesyl acetone, pristine, and squalene are all classified as aliphatic triterpenoids. These are commonly found in plant matter and fruits which are frequently consumed by humans. Squalene is an aliphatic triterpenoid, present in many foods including amaranth oil and olive oil. In human skin physiology, squalene is used as an antioxidant and moisturizer. It has also been reported to be used for treating skin disorders such as acne, atopic dermatitis, psoriasis, and seborrheic dermatitis [27]. Farnesyl acetone is found in the medicinal herb Costus pictus, also in tomato and watermelon [37]. In mushrooms, farnesyl acetone has been detected as a volatile component, accounting for up to 1% of volatiles in Suillus granulatus and up to 12% of Suillus luteus [29, 30]. Farnesol has been detected in plants and fungi, accounting for up to 16% of total volatiles in Chroogomphus rulitus [38]. However, farnesyl compounds are also endogenous in humans where they are involved in the production of cholesterol and protein tagging [38, 39]. A study conducted by Chaudary et al. (2009) demonstrated the chemopreventative effect of farnesol on skin tumorigenesis [40].

4.3. Fatty Acids

Fatty acids are common components found in nature, where they are present in animal or vegetable fats, oils, and waxes [41]. They form chains and are classified according to the length and number of carbon atoms present in the chain, such as short, medium, long, or very long [41]. Humans can synthesise the full range of essential dietary fatty acids used for energy besides the linoleic and alpha linolenic acids. Dietary fatty acids are used for energy through the beta-oxidation pathway in addition to assisting in cell wall synthesis and hormone manufacture [42].

Ethyl hexadecanoate (also known as ethyl palmitate) is the ethyl ester of palmitic acid. It is formed in humans in the nonoxidative metabolite pathway of ethanol and has been proposed as a biomarker for ethanol consumption [43]. It has also been listed as an emollient used in cosmetic products [44]. Ethyl tetracosonate is the ethyl ester of tetracosanoic acid which is present in peanut oil accounting for 1.1–2% mass fraction of total fatty acids [25]. Ethyl linoleate and ethyl linolenate are the ethyl esters of linoleic and alpha linolenic acid, respectively. According to PubChem (2021), hexadecanoic acid (palmitic acid) is used as an emollient in cosmetic products [45]. A study by Uddin et al. (2012) demonstrated that tetracosane had significant cytotoxic activity against HT-29 colon cancer cells and some toxicity against gastric cancer and estrogen-dependant breast cancer cells [46]. A recent study by Gao et al. (2019) demonstrated the use of hexanedioic acid (adipic acid) as a component of a hydrogel which shows potential for wound healing applications [47]. Additionally, adipic acid is used in cosmetics as a buffering agent [48].

Linoleic acid ethyl ester (ethyl linoleate) is an unsaturated fatty acid resulting from formal condensation of the carboxyl group of linoleic acid with the hydroxyl group of ethanol. It is used in many cosmetic products for its antibacterial and anti-inflammatory properties [49]. A recent study by Ko and Cho (2018) demonstrated the potential of ethyl linoleate as a noncytotoxic and skin whitening agent in medicine and cosmetic products [50]. Pentadecanoic acid has an uneven number of carbon atoms and is thought to be synthesised primarily by gut microflora in the rumen of cattle. Hence, the major dietary source of this fatty acid is milk, where it accounts for approximately 1% of milk fats [51]. It has been shown that pentadecanoic acid could serve as a signalling inhibitor in breast cancer cells [52]. Tetradecanoic acid (also known as myristic acid) is present in coconut oil and palm kernel fat accounting for approximately 16% mass fraction of total fatty acids [25]. It is also present in milk (11% mass fraction of total fatty acid), meat, and meat products [25]. Tetradecanoic acid is used as a cleansing and emulsifying agent in cosmetic products [53].

4.4. Flavonoids

The flavonoids comprise a group of low molecular weight compounds, of which roughly 4000 are known, and are separated into distinct subgroups: anthocyanidins, chalcones, flavanols, flavanones, flavones, isoflavones, and stannols [54]. They are ubiquitous in plants and have several biological functions. For example, they are responsible for pigmentation of many plants and fruits [55]. The flavonoids, trans-Cinnamic acid, chalcone, chrysin, and tectochrysin, are associated with a variety of health-promoting effects and are an important component in many nutraceutical, pharmaceutical, medicinal, and cosmetic applications [56–60]. This is due to their anticarcinogenic, anti-inflammatory, antimutagenic, and antioxidative properties [55]. Flavonoids are not classified as essential human nutrients per se, but a high dietary intake of flavonoids is thought to be associated with lowered cancer and cardiovascular disease risk [54]. 2,4-Dihydroxychalcone is a flavonoid abundant in the leaves of Oxytropis falcata, a leguminous plant also known as locoweed. This plant has been widely used in Chinese/Tibetan herbal medicine. In addition to its antioxidant activity, it also exhibits antitumor activity [61, 62]. Equol is the major intestinal bacterial metabolite of the isoflavanone diadzin in 25–60% of the population and is influenced by diet [63]. Those consuming a diet high in diadzin (e.g., vegetarian diets and/or those containing soya) were more likely to metabolise the material to equol [63]. Equol has been shown to have antiaging properties and antiandrogen activity [64, 65]. Naringenin is found in many citrus fruits and has been measured in grapefruit juice at concentrations of 100–800 mg/L [23]. There is growing evidence showing the pharmacological effects of naringenin which include anticancer, anti-inflammatory, antimicrobial, antimutagenic, and hepatoprotective properties [66]. Pinocembrin is a major flavanone found in honey and propolis, the resinous substance used by bees to seal honeycombs and used as a health food [67]. Pinocembrin has shown potential for use as an antioxidative, anti-inflammatory, antimicrobial, and antitumor agent [68].

4.5. Phenolic Compounds

Results reveal 2-methoxy-4-vinylphenol to be present in many products where production involves the use of yeast and/or cooking. It is also a component of beer, especially wheat beer, formed by the conversion of ferulic acid during the fermenting process [69]. In a study by Kim et al. (2019), it was shown that 2-methoxy-4-vinylphenol possesses anticancer properties and exhibits antiaging and antioxidant activity [70, 71].

4.6. Tocopherols

Alpha-tocopherols are part of a group of fat-soluble compounds known as vitamin E. Along with being the most common form of vitamin E present in nature, alpha-tocopherols are also the most biologically active [72]. These can be found in foods such as avocados, nuts, and seeds. In a study by Weber et al. (1997), it was shown that a topical application of alpha-tocopherol to mouse skin prior to exposure of UV-irradiation resulted in the preservation of antioxidants [57, 73]. Conversely, without prior application of the tocopherol, the antioxidants present in the skin were destroyed after the irradiation. Alpha-tocopherolquinone is a metabolite of alpha-tocopherol [74]. Vitamin E derivatives such as alpha-tocopherolquinone act as an important physiological antioxidant. Alpha-tocopherolquinone has further demonstrated its potential as a biomarker for oxidative stress [75].

Vitamin E is an essential nutrient obtained by external sources such as fresh vegetables, vegetable oils, cereals, and nuts. Vitamin E has been demonstrated to be of importance in recent dermatological studies due to its antioxidant properties. Experimental evidence suggests that topical application and oral consumption of vitamin E have anticarcinogenic, photoprotective, and skin barrier-stabilizing properties [76]. Vitamin E acetate has elicited a significant interest for its role in assisting in curing burn injuries, particularly for its antioxidant action which occurs during tissue reperfusion. Reactive oxygen species and free radicals are produced during the phase of reperfusion of ischemic tissues, damaging numerous cell components, including nucleic acids, lipids, and proteins. It has been shown that a bioadhesive film containing vitamin E acetate could facilitate skin regeneration and wound healing through the controlled release of the vitamin E acetate [77].

5. Potential Health Risks of Phytochemicals Identified in the Galenia africana Extract

Information from the US Dietary Reference Intake (DRI), Joint FAO/WHO Expert Committee on Food Additives (JECFA), and Beare-Rogers et al. (2009) IUPAC Technical Report was used to establish average daily background dietary intake values (Table 1) [18,25,78]. The background dietary intake of the constituents of G. africana was analysed using the European Union Pesticide Residue Intake Model (EU PRIMO) consumer risk assessment model, which informed a risk assessment for consumers [79, 80].

Based on the G. africana phytochemical data, it was observed that most compounds were already present in the general human diet and therefore should not pose a risk to human health. Potentially relevant components, besides cinnamic acid, the coumarins, equol, and 2-methoxy-4-vinyl phenol, were all found to be nontoxic following preliminary chronic and acute consumer risk assessments. The dietary intakes and potential health risks for the phytochemicals in Table 1, as far as could be established from the literature, are summarised below.

For aliphatics in general, Tennant (2004) has estimated that the average intake of each of the mixed alkanes is 0.01–0.02 mg/kg/day [81]. Based on this data and information from the European Food Safety Authority, which considered and listed paraffin oils for use as a pesticide active ingredient, it was deemed that no risk assessment would be necessary as the straight chain alkanes were toxicologically nonrelevant.

The aliphatic triterpenoid, squalene, is especially prevalent in olive oils, and as a result human dietary intake varies greatly according to the geographical location where intake is estimated at 30 mg/day in the USA but increases to 200–400 mg/day in Mediterranean countries [26]. No quantitative information was available regarding the dietary intakes of faresyl acetone and hexahydrofarnesyl. However, hexahydrofarnesyl acetone undergoes beta-oxidation and is unlikely to pose greater hazards than fatty acids or aliphatics. Farnesyl acetone intake can be approximated as it is approved as a flavouring agent by JECFA with an estimated daily intake of 9 µg/day.

According to Madigan et al. (1994), the phenolic compound 2-methoxy-4-vinylphenol is present in wheat beer at a concentration of 0.68 mg/L [82]. The average Czech Republic intake of beer is 156 L/year giving rise to an average daily intake of 2-methoxy-4-vinylphenol from beer at 0.29 mg/day. Consuming 2 L of beer in one day, as might occur occasionally, results in consumption of 1.36 mg/day.

According to Kennedy et al., (1999) the dietary intake of fatty acids in the USA is between 41 and 117 g/day with saturated fat accounting for 14–42 g of this amount [55, 83]. Given that fatty acids are a significant part of the normal human diet, they are not toxicologically relevant components of the extract and may be excluded from risk assessments.

The potential link between flavonoid intake and health has led to a number of studies measuring the dietary intake of flavonoids in humans. These have produced differing results ranging from 23 mg/day to 1 g/day [84–86]. As such, the potential dietary intake of the many flavonoids may account for up to 600 mg/day if all flavonoids are considered.

As a tocopherol, the recommended daily intake of vitamin E has been set by many countries. According to the US DRI of alpha-tocopherol, intake is set at 15 mg/day with an upper tolerable intake of 1,000 mg/kg [87].

6. Conclusions

Galenia africana is a plant of traditional medicinal and commercial relevance in South Africa. In this review, the importance and relevance of the phytochemical constituents and potential risks relating to exposure to the G. africana extract were concluded in a descriptive manner. Phytochemical screening results indicate the relative chemistry and concentrations of the compounds in the plant extract. Literature also shows that several compounds present in the G. africana extract exhibit anti-inflammatory, antioxidant, and antimicrobial activities and wound healing which supports the traditional medicinal use of the plant by indigenous people. Furthermore, it was revealed that none of the potentially relevant compounds in G. africana were expected to cause undue risk to human health. This data regarding the potential risks related to the ingestion of G. africana extract could be used to infer the potential risks relating to the accidental exposure to these phytochemical compounds when exposed to human skin upon topical application. On this basis, the effect of the Galenia africana extract on human skin in quantities similar to those described in this review should not cause undue risk to human health. However, it is important that further studies be performed using this plant to determine pharmacological action and mechanism of action, which has the potential to lead to the development of G. africana as a therapeutic agent.

Disclosure

Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and, therefore, the NRF does not accept any liability in regard thereto.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

The authors wish to thank Dr. Lawrence Ticha for providing the G. africana extract fractions for GC-MS analysis, and APC Chemicals Ltd, United Kingdom, for performing the dietary intake risk analysis studies. The authors greatly appreciate funding received by the National Research Foundation (NRF), South Africa, for this study

References

World Health Organisation (WHO), The World Medicines Situation Traditional Medicines: Global Situation, Issues and Challenges, World Health Organisation (WHO), Geneva, Switzerland, 2011, http://www.who.int/medicines/areas/policy/world_medicines_situation/WMS_ch18_ wTraditionalMed.pdf Available at:.
K. Naidoo and R. M. Coopoosamy, “A comparative analysis of two medicinal plants used to treat common skin conditions in South Africa,” African Journal of Pharmacy and Pharmacology, vol. 5, no. 3, pp. 393–397, 2011.
View at: Publisher Site | Google Scholar
A. R. Ndhlala, B. Ncube, A. Okem, R. B. Mulaudzi, and J. Van Staden, “Toxicology of some important medicinal plants in southern Africa,” Food and Chemical Toxicology, vol. 62, pp. 609–621, 2013.
View at: Publisher Site | Google Scholar
T. S. Kellerman, J. A. W. Coetzer, and T. W. Naude, Plant Poisoning and Mycotoxicosis of Livestock in Southern Africa, Oxford University Press, Oxford, UK, 1988.
J. J. Van der Lugt, R. A. Schultz, N. Fourie, L. J. Hon, P. Jordaan, and L. Labuschagne, “Galenia africana L. poisoning in sheep and goats: hepatic and cardiac changes,” Onderstepoort Journal of Veterinary Research, vol. 59, pp. 323–333, 1992.
View at: Google Scholar
J. J. J. De Beer and B.-E. Van Wyk, “An ethnobotanical survey of the agter-hantam, northern Cape province, South Africa,” South African Journal of Botany, vol. 77, no. 3, pp. 741–754, 2011.
View at: Publisher Site | Google Scholar
Foden, W. & Potter, L. 2005. Galenia Africana L. National Assessment: Red List of South African Plants Version 2017.1. Accessed on 2019/10/03.
L. Simons and N. Allsopp, “Rehabilitation of rangelands in Paulshoek, Namaqualand: understanding vegetation change using biophysical manipulations,” Journal of Arid Environments, vol. 70, no. 4, pp. 755–766, 2007.
View at: Publisher Site | Google Scholar
Le Roux, P. M., Kotze, C. D., Nel, G. P. and Glen, H. F., 1994. Bossieveld-grazing Plants of the Karoo and Karoo-like areas [South Africa].
J. M. Watt and M. G. Breyer-Brandwijk, The Medicinal and Poisonous Plants of Southern and Eastern Africa, E. & S. Livingstone, Edinburgh, Scotland, 1962.
R. Sharma, Antibacterial and Anti-inflammatory Activity of Syzygium Jambos and Leucosidea Sericea in Addressing Acne Vulgaris, University of Pretoria, Pretoria, South Africa, 2014, Doctoral dissertation.
S. Dubey, S. Maity, M. Singh, S. A. Saraf, and S. Saha, “Phytochemistry, pharmacology and toxicology of Spilanthes acmella: a review,” Advances in Pharmacological and Pharmaceutical Sciences, vol. 2013, Article ID 423750, 2013.
View at: Publisher Site | Google Scholar
L. A. Ticha, J. A. Klaasen, I. R. Green, S. Naidoo, B. Baker, and R. D. Pietersen, “Phytochemical and antimicrobial screening of flavanones and chalcones from Galenia africana and dicerothamnus rhinocerotis,” Natural product communications, vol. 10, no. 7, pp. 1185–1890, 2015.
View at: Publisher Site | Google Scholar
F. A. Vries, H. El Bitar, I. R. Green et al., “An antifungal active extract from the aerial parts of Galenia africana,” in Proceedings of the 11th NAPRECA Symposium Book of Proceedings, pp. 123–131, Antananarivo, Madagascar, 2005, August.
View at: Google Scholar
S. P. N. Mativandlela, T. Muthivhi, H. Kikuchi et al., “Antimycobacterial flavonoids from the leaf extract of Galenia africana,” Journal of Natural Products, vol. 72, no. 12, pp. 2169–2171, 2009.
View at: Publisher Site | Google Scholar
A. K. Al-Asmari, M. T. Athar, H. M. Al-Shahrani, S. I. Al-Dakheel, and M. A. Al-Ghamdi, “Efficacy of Lepidium sativum against carbon tetra chloride induced hepatotoxicity and determination of its bioactive compounds by GC⿿MS,” Toxicology reports, vol. 2, pp. 1319–1326, 2015.
View at: Publisher Site | Google Scholar
P. Chang, D. Anderson, and K. Thompson, “Flavonoids of buckwheat honeys,” in Proceedings of the 8th ISB, Qingdao, China, October 2001.
View at: Google Scholar
World Health Organization, Evaluations of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), World Health Organization, Geneva, Switzerland, 2021, https://apps.who.int/food-additives-contaminants-jecfa-database/search.aspx.
J. Schmidhuber, in The EU Diet–Evolution, Evaluation And Impacts Of The CAP, WHO Forum on “Trade and Healthy Food and Diets”, Montreal, Canada, 2007.
G. Gattuso, D. Barreca, C. Gargiulli, U. Leuzzi, and C. Caristi, “Flavonoid composition of citrus juices,” Molecules, vol. 12, no. 8, pp. 1641–1673, 2007.
View at: Publisher Site | Google Scholar
Y. Arai, M. Uehara, Y. Sato et al., “Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake,” Journal of Epidemiology, vol. 10, no. 2, pp. 127–135, 2000.
View at: Publisher Site | Google Scholar
L. K. Boker, Y. T. Van der Schouw, M. J. J. De Kleijn, P. F. Jacques, D. E. Grobbee, and P. H. M. Peeters, “Intake of dietary phytoestrogens by Dutch women,” Journal of Nutrition, vol. 132, no. 6, pp. 1319–1328, 2002.
View at: Publisher Site | Google Scholar
C. F. Skibola and M. T. Smith, “Potential health impacts of excessive flavonoid intake,” Free Radical Biology & Medicine, vol. 29, no. 3-4, pp. 375–383, 2000.
View at: Publisher Site | Google Scholar
European Food Safety Authority (EFSA), “Dietary reference values for nutrients summary report,” European Food Safety Authority (EFSA), vol. 14, no. 12, Article ID e15121E, 2017.
View at: Publisher Site | Google Scholar
J. L. Beare-Rogers, A. Dieffenbacher, and J. V. Holm, “Lexicon of lipid nutrition (IUPAC technical report),” Pure and Applied Chemistry, vol. 73, no. 4, pp. 685–744, 2001.
View at: Publisher Site | Google Scholar
H. L. Newmark, “Squalene, olive oil, and cancer risk: a review and hypothesis,” Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 6, no. 12, pp. 1101–1103, 1997.
View at: Google Scholar
K. Wołosik, M. Knaś, A. Zalewska, M. Niczyporuk, and A. W. Przystupa, “The importance and perspective of plant-based squalene in cosmetology,” Journal of Cosmetic Science, vol. 64, no. 1, pp. 59–66, 2013.
View at: Google Scholar
I. Goldberg and R. Williams, “Biotechnology and food ingredients P46 ISBN0442002726,” Food Technology and Biotechnology, vol. 8, 1991.
View at: Google Scholar
S. Rapior, C. Marion, Y. Pélissier, and J.-M. Bessière, “Volatile composition of fourteen species of fresh wild mushrooms (Boletales),” Journal of Essential Oil Research, vol. 9, no. 2, pp. 231–234, 1997.
View at: Publisher Site | Google Scholar
S. Rapior, S. Cavalié, C. Andary, Y. Pélissier, C. Marion, and J.-M. Bessière, “Investigation of some volatile components of seven fresh wild mushrooms (Basidiomycetes),” Journal of Essential Oil Research, vol. 8, no. 2, pp. 199–201, 1996.
View at: Publisher Site | Google Scholar
R. Zamora-Ros, C. Andres-Lacueva, R. M. Lamuela-Raventós et al., “Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort,” British Journal of Nutrition, vol. 100, no. 1, pp. 188–196, 2008.
View at: Publisher Site | Google Scholar
J.-G. Chung, L. R. Garrett, P. E. Byers, and M. A. Cuchens, “A survey of the amount of pristane in common fruits and vegetables,” Journal of Food Composition and Analysis, vol. 2, no. 1, pp. 22–27, 1989.
View at: Publisher Site | Google Scholar
D. Janes, H. Prosen, I. Kreft, and S. Kreft, “Aroma compounds in buckwheat (Fagopyrum esculentum Moench) groats, flour, bran and husk,” Cereal Chemistry, vol. 97, no. 2, pp. 141–143, 2010.
View at: Google Scholar
R. Brigelius‐Flohé and M. G. Traber, “Vitamin E: function and metabolism,” The FASEB Journal, vol. 13, no. 10, pp. 1145–1155, 1999.
View at: Google Scholar
O. Konovalova, E. Gergel, and V. Herhel, “GC-MS analysis of bioactive components of shepherdia argentea (pursh.) nutt. From Ukrainian flora,” Journal of the Pharmaceutical Innovation, vol. 2, no. 6, 2013.
View at: Google Scholar
M. Rukaiyat, S. Garba, and S. Labaran, “Antimicrobial activities of hexacosane isolated from Sanseveria liberica (Gerome and Labroy) plant,” Advancement in Medicinal Plant Research, vol. 3, no. 3, pp. 120–125, 2015.
View at: Google Scholar
B. Jose and L. J. Reddy, “Analysis of the essential oils of the stems, leaves and rhizomes of the medicinal plant Costus pictus from southern India,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 2, no. Suppl 2, pp. 100-101, 2010.
View at: Google Scholar
A. G. Staines, P. Sindelar, M. W. H. Coughtrie, and B. Burchell, “Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1,” Biochemical Journal, vol. 384, no. 3, pp. 637–645, 2004.
View at: Publisher Site | Google Scholar
J. L. Goldstein and M. S. Brown, “Regulation of the mevalonate pathway,” Nature, vol. 343, no. 6257, pp. 425–430, 1990.
View at: Publisher Site | Google Scholar
S. C. Chaudhary, M. S. Alam, M. S. Siddiqui, and M. Athar, “Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis,” Life Sciences, vol. 85, no. 5-6, pp. 196–205, 2009.
View at: Publisher Site | Google Scholar
E. W. Lusas, M. N. Riaz, M. S. Alam, and R. Clough, “Animal and vegetable fats, oils, and waxes,” Handbook of Industrial Chemistry and Biotechnology, vol. 8, pp. 823–932, 2017.
View at: Publisher Site | Google Scholar
A. Kumari, “Beta oxidation of fatty acids,” Sweet Biochemistry, vol. 8, pp. 17–19, 2018.
View at: Publisher Site | Google Scholar
B. L. Soderberg, R. O. Salem, C. A. Best, J. E. Cluette-Brown, and M. Laposata, “Fatty acid ethyl esters: ethanol metabolites that reflect ethanol intake,” Pathol. Patterns Rev., vol. 119, no. 1, pp. 94–99, 2003.
View at: Publisher Site | Google Scholar
National Center for Biotechnology Information, Pubchem Compound Summary For CID 12366, Ethyl Palmitate, PubChem, Shanghai, China, 2021.
National Center for Biotechnology Information, Pubchem Compound Summary For CID 985, Palmitic Acid, PubChem, Shanghai, China, 2021, https://pubchem.ncbi.nlm.nih.gov/compound/Palmitic-acid.
S. J. Uddin, D. Grice, and E. Tiralongo, “Evaluation of cytotoxic activity of patriscabratine, tetracosane and various flavonoids isolated from the Bangladeshi medicinal plantAcrostichum aureum,” Pharmaceutical Biology, vol. 50, no. 10, pp. 1276–1280, 2012.
View at: Publisher Site | Google Scholar
L. Gao, Y. Zhou, J. Peng et al., “A novel dual-adhesive and bioactive hydrogel activated by bioglass for wound healing,” NPG Asia Materials, vol. 11, no. 1, pp. 1–11, 2019.
View at: Publisher Site | Google Scholar
National Center for Biotechnology Information, Pubchem Compound Summary For CID 196, Adipic Acid, PubChem, Shanghai, China, 2021, https://pubchem.ncbi.nlm.nih.gov/compound/Adipic-acid.
S. Y. Park, R. Seetharaman, M. J. Ko et al., “Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cells,” International Immunopharmacology, vol. 19, no. 2, pp. 253–261, 2014.
View at: Publisher Site | Google Scholar
G.-A. Ko and S. Kim Cho, “Ethyl linoleate inhibits α-MSH-induced melanogenesis through Akt/GSK3β/β-catenin signal pathway,” Korean Journal of Physiology and Pharmacology, vol. 22, no. 1, p. 53, 2018.
View at: Publisher Site | Google Scholar
A. E. Smedman, I.-B. Gustafsson, L. G. Berglund, and B. O. Vessby, “Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors,” The American Journal of Clinical Nutrition, vol. 69, no. 1, pp. 22–29, 1999.
View at: Publisher Site | Google Scholar
N. B. To, Y. T.-K. Nguyen, J. Y. Moon, M. K. Ediriweera, and S. K. Cho, “Pentadecanoic acid, an odd-chain fatty acid, suppresses the stemness of MCF-7/SC human breast cancer stem-like cells through JAK2/STAT3 signaling,” Nutrients, vol. 12, no. 6, p. 1663, 2020.
View at: Publisher Site | Google Scholar
National Center for Biotechnology Information, Pubchem Compound Summary For CID 11005, Myristic Acid, PubChem, Shanghai, China, 2021, https://pubchem.ncbi.nlm.nih.gov/compound/Myristic-acid.
C. Weber, M. Podda, M. Rallis, J. J. Thiele, M. G. Traber, and L. Packer, “Efficacy of topically applied tocopherols and tocotrienols in protection of murine skin from oxidative damage induced by UV-irradiation,” Free Radical Biology and Medicine, vol. 22, no. 5, pp. 761–769, 1997.
View at: Publisher Site | Google Scholar
E. T. Kennedy, S. A. Bowman, and R. Powell, “Dietary-fat intake in the US population,” Journal of the American College of Nutrition, vol. 18, no. 3, pp. 207–212, 1999.
View at: Publisher Site | Google Scholar
Y.-C. Hseu, M. Korivi, F.-Y. Lin et al., “Trans -cinnamic acid attenuates UVA-induced photoaging through inhibition of AP-1 activation and induction of Nrf2-mediated antioxidant genes in human skin fibroblasts,” Journal of Dermatological Science, vol. 90, no. 2, pp. 123–134, 2018.
View at: Publisher Site | Google Scholar
A. Modzelewska, C. Pettit, G. Achanta, N. E. Davidson, P. Huang, and S. R. Khan, “Anticancer activities of novel chalcone and bis-chalcone derivatives,” Bioorganic & Medicinal Chemistry, vol. 14, no. 10, pp. 3491–3495, 2006.
View at: Publisher Site | Google Scholar
B. Y. Khoo, S. L. Chua, and P. Balaram, “Apoptotic effects of chrysin in human cancer cell lines,” International Journal of Molecular Sciences, vol. 11, no. 5, pp. 2188–2199, 2010.
View at: Publisher Site | Google Scholar
S.-B. Oh, C. J. Hwang, S.-Y. Song et al., “Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3,” Cancer Letters, vol. 353, no. 1, pp. 95–103, 2014.
View at: Publisher Site | Google Scholar
S. Lee, K. S. Kim, Y. Park, K. H. Shin, and B.-K. Kim, “In vivo anti-oxidant activities of tectochrysin,” Archives of Pharmacal Research, vol. 26, no. 1, pp. 43–46, 2003.
View at: Publisher Site | Google Scholar
O. Popoola, J. Marnewick, F. Rautenbach, F. Ameer, E. Iwuoha, and A. Hussein, “Inhibition of oxidative stress and skin aging-related enzymes by prenylated chalcones and other flavonoids from Helichrysum teretifolium,” Molecules, vol. 20, no. 4, pp. 7143–7155, 2015.
View at: Publisher Site | Google Scholar
C. Lou, M. Wang, G. Yang et al., “Preliminary studies on anti-tumor activity of 2′,4′-dihydroxychalcone isolated from Herba Oxytropis in human gastric cancer MGC-803 cells,” Toxicology in Vitro, vol. 23, no. 5, pp. 906–910, 2009.
View at: Publisher Site | Google Scholar
K. D. R. Setchell and S. J. Cole, “Method of defining equol-producer status and its frequency among vegetarians,” Journal of Nutrition, vol. 136, no. 8, pp. 2188–2193, 2006.
View at: Publisher Site | Google Scholar
E. D. Lephart, T. D. Lund, K. D. R. Setchell, and R. J. Handa, “Use of equol for treating skin diseases,” U.S. Patent, vol. 8, p. 668, 2014.
View at: Google Scholar
U. Magnet, C. Urbanek, D. Gaisberger et al., “Topical equol preparation improves structural and molecular skin parameters,” International Journal of Cosmetic Science, vol. 39, no. 5, pp. 535–542, 2017.
View at: Publisher Site | Google Scholar
B. Salehi, P. Fokou, M. Sharifi-Rad et al., “The therapeutic potential of naringenin: a review of clinical trials,” Pharmaceuticals, vol. 12, no. 1, p. 11, 2019.
View at: Publisher Site | Google Scholar
M. Medić-Šarić, V. Rastija, M. Bojić, and Ž. Maleš, “From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine,” Nutrition Journal, vol. 8, no. 1, pp. 1–18, 2009.
View at: Google Scholar
A. Rasul, F. M. Millimouno, W. Ali Eltayb, M. Ali, J. Li, and X. Li, “Pinocembrin: a novel natural compound with versatile pharmacological and biological activities,” BioMed Research International, vol. 2013, Article ID 379850, 2013.
View at: Publisher Site | Google Scholar
S. Coghe, K. Benoot, F. Delvaux, B. Vanderhaegen, and F. R. Delvaux, “Ferulic acid release and 4-vinylguaiacol formation during brewing and fermentation: indications for feruloyl esterase activity in Saccharomyces cerevisiae,” Journal of Agricultural and Food Chemistry, vol. 52, no. 3, pp. 602–608, 2004.
View at: Publisher Site | Google Scholar
D.-H. Kim, S.-I. Han, B. Go et al., “2-methoxy-4-vinylphenol attenuates migration of human pancreatic cancer cells via blockade of fak and akt signaling,” Anticancer Research, vol. 39, no. 12, pp. 6685–6691, 2019.
View at: Publisher Site | Google Scholar
K. Jung, R. J. C. Everson, B. Joshi, P. A. Bulsara, R. Upasani, and M. J. Clarke, “Structure-function relationship of phenolic antioxidants in topical skin health products,” International Journal of Cosmetic Science, vol. 39, no. 2, pp. 217–223, 2017.
View at: Publisher Site | Google Scholar
C. Colosio, E. Corsini, W. Barcellini, and M. Maroni, “Immune parameters in biological monitoring of pesticide exposure: current knowledge and perspectives,” Toxicology Letters, vol. 108, no. 2-3, pp. 285–295, 1999.
View at: Publisher Site | Google Scholar
F. Van Wijk and S. Nierkens, “Assessment of drug-induced immunotoxicity in animal models,” Drug Discovery Today: Technologies, vol. 3, no. 1, pp. 103–109, 2006.
View at: Publisher Site | Google Scholar
J. Descotes, “Importance of immunotoxicity in safety assessment: a medical toxicologist’s perspective,” Toxicology Letters, vol. 149, no. 1-3, pp. 103–108, 2004.
View at: Publisher Site | Google Scholar
E. Niki and N. Noguchi, “Antioxidant action of vitamin E in vivo as assessed from its reaction products with multiple biological oxidants,” Free Radical Research, vol. 12, pp. 1–33, 2020.
View at: Google Scholar
J. J. Thiele, S. N. Hsieh, and S. Ekanayake-Mudiyanselage, “Vitamin E: critical review of its current use in cosmetic and clinical dermatology,” Dermatologic Surgery: official publication for American Society for Dermatologic Surgery, vol. 31, pp. 805–813, 2005.
View at: Publisher Site | Google Scholar
G. G. Pereira, S. S. Guterres, A. G. Balducci, P. Colombo, and F. Sonvico, “Polymeric films loaded with vitamin E and Aloe vera for topical application in the treatment of burn wounds,” BioMed Research International, vol. 2014, 2014.
View at: Publisher Site | Google Scholar
National Institutes of Health. “Nutrient Recommendations: Dietary Reference Intakes (DRI).” Retrieved 15 June, 2021, from https://ods.od.nih.gov/HealthInformation/Dietary_Reference_Intakes.aspx.
European Food Safety Authority (EFSA), M. Anastassiadou, A. Brancato et al., “Pesticide Residue intake model‐EFSA PRIMo revision 3.1: (update of EFSA PRIMo revision 3),” vol. 16, no. 3, p. 1605E, 2019.
View at: Publisher Site | Google Scholar
European Food Safety Authority (EFSA). 2021. Pesticide Evaluation: Tools. [online] Available at: <https://www.efsa.europa.eu/en/applications/pesticides/tools> Accessed 21 April 2021.
D. R. Tennant, “The usage, occurrence and dietary intakes of white mineral oils and waxes in Europe,” Food and Chemical Toxicology, vol. 42, no. 3, pp. 481–492, 2004.
View at: Publisher Site | Google Scholar
D. Madigan, I. McMurrough, and M. R. Smyth, “Determination of proanthocyanidins and catechins in beer and barley by high-performance liquid chromatography with dual-electrode electrochemical detection,” The Analyst, vol. 119, no. 5, pp. 863–868, 1994.
View at: Publisher Site | Google Scholar
L. S. Ching and S. Mohamed, “Alpha-tocopherol content in 62 edible tropical plants,” Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3101–3105, 2001.
View at: Publisher Site | Google Scholar
M. G. Hertog, P. C. Hollman, M. B. Katan, and D. Kromhout, “Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the netherlands,” Nutrition Cancer, vol. 20, 1993.
View at: Google Scholar
S. M. Somerset and L. Johannot, “Dietary flavonoid sources in Australian adults,” Nutrition and Cancer, vol. 60, no. 4, pp. 442–449, 2008.
View at: Publisher Site | Google Scholar
J. Kuhnau, “Flavonoids. A class of semi-essential food components: their role in human nutrition,” World Review of Nutrition & Dietetics, vol. 20, 1976.
View at: Google Scholar
N. I. Krinsky, G. R. Beecher, R. F. Burk et al., Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, Institute of Medicine, Cambridge, MA, USA, 2000.

Copyright

Copyright © 2022 Dario Heredia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2326

Downloads

981

Citations